Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir. 1997

A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592
D016879 Salvage Therapy A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases. Salvage Treatment,Therapy, Salvage,Salvage Therapies,Salvage Treatments,Therapies, Salvage,Treatment, Salvage,Treatments, Salvage
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related
D017245 Foscarnet An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. Phosphonoformate,Phosphonoformic Acid,Foscarnet Barium (2:3) Salt,Foscarnet Calcium (2:3) Salt,Foscarnet Disodium Salt,Foscarnet Magnesium (2:3) Salt,Foscarnet Manganese (2+) (2:3) Salt,Foscarnet Sodium,Foscarnet Sodium Hexahydrate,Foscarnet Trilithium Salt,Foscarnet Tripotassium Salt,Foscarnet Trisodium Salt,Foscavir,Trisodium Phosphonoformate
D017726 Cytomegalovirus Retinitis Infection of the retina by cytomegalovirus characterized by retinal necrosis, hemorrhage, vessel sheathing, and retinal edema. Cytomegalovirus retinitis is a major opportunistic infection in AIDS patients and can cause blindness. Retinitis, Cytomegalovirus,Cytomegaloviral Retinitis,Retinitis, Cytomegaloviral
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
June 1991, The Journal of infectious diseases,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
January 1995, European journal of ophthalmology,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
May 1995, American journal of ophthalmology,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
July 1996, American journal of ophthalmology,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
January 1990, Journal of acquired immune deficiency syndromes,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
September 2023, European journal of ophthalmology,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
October 1993, Archives of ophthalmology (Chicago, Ill. : 1960),
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
November 1996, German journal of ophthalmology,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
April 1995, Clinical pharmacology and therapeutics,
A J Mueller, and M A Jacobson, and S Hurwitz, and E L Chuang, and D N Friedberg, and S J Haidt, and M H Heinemann, and D A Jabs, and H J Kaplan, and W R Freeman
August 1992, Lancet (London, England),
Copied contents to your clipboard!